What Inhibits Natural Killers' Performance in Tumour

Ines Papak1, Elżbieta Chruściel1, Katarzyna Dziubek1

  • 1International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.

Insights

Natural killer (NK) cells are innate immune cells that kill tumor cells by balancing activating and inhibitory signals. This review explores how NK cells eliminate tumors and the inhibitory factors that limit their cancer-fighting potential.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial innate immune cells involved in tumor surveillance and elimination.
  • NK cell cytotoxicity is regulated by a complex interplay between activating and inhibitory receptors.
  • NK cell-based immunotherapies are emerging as a promising cancer treatment modality.

Purpose of the Study:

  • To review the mechanisms by which NK cells lyse tumor cells.
  • To discuss the inhibitory signals that impair NK cell cytotoxic activity.
  • To highlight strategies aimed at enhancing NK cell-based cancer immunotherapy.

Main Methods:

  • This review synthesizes current knowledge from preclinical studies and clinical trials.
  • Literature search and analysis of published research on NK cell function and immunotherapy.
  • Discussion of receptor-ligand interactions and signaling pathways governing NK cell activation and inhibition.

Main Results:

  • NK cells possess intrinsic tumor-lysing capabilities independent of antigen presentation.
  • The balance of activating and inhibitory receptor engagement dictates NK cell effector function.
  • Several strategies are being developed to overcome inhibitory signals and boost NK cell anti-tumor activity.

Conclusions:

  • Understanding NK cell activation and inhibition is key to developing effective immunotherapies.
  • Modulating NK cell receptor pathways offers a promising avenue for cancer treatment.
  • Further research is needed to fully harness the therapeutic potential of NK cells in oncology.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
2.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K